152 related articles for article (PubMed ID: 14576953)
21. HPV Screening Test for the Detection of Precancerous Cervical Lesions and Cervical Cancer in Israeli Women.
Feinberg T; Yehuda-Shnaidman E; Wolf T; Sandbank J; Segal J; Vaknin Z; Schejter E
Acta Cytol; 2021; 65(6):494-500. PubMed ID: 34515031
[TBL] [Abstract][Full Text] [Related]
22. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
23. Incidence of Pap test abnormalities within 3 years of a normal Pap test--United States, 1991-1998.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(44):1001-3. PubMed ID: 11097139
[TBL] [Abstract][Full Text] [Related]
24. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of endocervical curettage for detecting dysplastic lesions in women with atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) Papanicolaou smears.
Poomtavorn Y; Suwannarurk K; Thaweekul Y; Maireang K
Asian Pac J Cancer Prev; 2014; 15(8):3461-4. PubMed ID: 24870740
[TBL] [Abstract][Full Text] [Related]
26. Ethnic Disparities for Gynecologic Cancers in Israel.
Kadan Y; Fishman A; Helpman L
J Racial Ethn Health Disparities; 2020 Jun; 7(3):421-427. PubMed ID: 31768965
[TBL] [Abstract][Full Text] [Related]
27. [CERVICAL CANCER IN ISRAEL 2016: FACTS, INSIGHTS AND THOUGHTS FOR THE FUTURE].
Fisher M; Schejter E; Solt I; Renart G
Harefuah; 2016 Sep; 155(9):563-566. PubMed ID: 28530082
[TBL] [Abstract][Full Text] [Related]
28. Abnormal Pap smears: a comparison of total abdominal hysterectomy and cone biopsy in management.
Onah HE; Iyoke CA
J Obstet Gynaecol; 2006 Jan; 26(1):48-51. PubMed ID: 16390711
[TBL] [Abstract][Full Text] [Related]
29. Association between high-grade squamous intraepithelial lesion, age, and number and interval of smears in women in Araçatuba, Brazil.
Xavier-Júnior JCC; Camilo-Júnior DJ; Gardini APHGDA; D'ávilla SCGP; Mattar NJ
Int J Gynaecol Obstet; 2018 Oct; 143(1):110-111. PubMed ID: 29904914
[No Abstract] [Full Text] [Related]
30. Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J
N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872
[TBL] [Abstract][Full Text] [Related]
31. Oral contraceptive pills are associated with artifacts in ThinPrep Pap smears that mimic low-grade squamous intraepithelial lesions.
Morrison C; Prokorym P; Piquero C; Wakely PE; Nuovo GJ
Cancer; 2003 Apr; 99(2):75-82. PubMed ID: 12704686
[TBL] [Abstract][Full Text] [Related]
32. Cervical intraepithelial neoplasia and associated condylomatous lesions. A preliminary report on 4,764 women from Northern Israel.
Suprun HZ; Schwartz J; Spira H
Acta Cytol; 1985; 29(3):334-40. PubMed ID: 3859132
[TBL] [Abstract][Full Text] [Related]
33. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
34. The magnitude and predictors of cervical squamous intraepithelial lesions among women in Enugu, Nigeria: a cross-sectional study of women in a low-resource setting.
Omeke CA; Enebe JT; Ugwu AI; Onyishi NT; Omeke MC; Enebe NO; Izuka EO; Aniwada EC
Pan Afr Med J; 2022; 41():130. PubMed ID: 35480408
[TBL] [Abstract][Full Text] [Related]
35. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M
Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189
[TBL] [Abstract][Full Text] [Related]
36. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women.
Arbel-Alon S; Menczer J; Feldman N; Glezerman M; Yeremin L; Friedman E
Int J Gynecol Cancer; 2002; 12(6):741-4. PubMed ID: 12445252
[TBL] [Abstract][Full Text] [Related]
37. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
[TBL] [Abstract][Full Text] [Related]
38. Organization and evolution of organized cervical cytology screening in Thailand.
Khuhaprema T; Attasara P; Srivatanakul P; Sangrajrang S; Muwonge R; Sauvaget C; Sankaranarayanan R
Int J Gynaecol Obstet; 2012 Aug; 118(2):107-11. PubMed ID: 22613493
[TBL] [Abstract][Full Text] [Related]
39. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
[TBL] [Abstract][Full Text] [Related]
40. Uterine cervix conization based on Pap smear results: the "see and treat" approach.
Meirovitz M; Gatt D; Dreiher J; Shaco-Levy R
Isr Med Assoc J; 2014 May; 16(5):303-6. PubMed ID: 24979836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
